Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PALI
Stock Latest News
The Fly
Palisade Bio files to sell 8.9M shares of common stock for holders
5d ago
PALI
Premium
Ratings
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
12d ago
PALI
Premium
Company Announcements
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
13d ago
PALI
Premium
The Fly
Palisade Bio announces new data from ongoing program evaluating PALI-2108
13d ago
PALI
Premium
The Fly
Palisade Bio receives notice of allowance for patent of PALI-2108 in China
20d ago
PALI
Premium
Company Announcements
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment
21d ago
PALI
Premium
Company Announcements
Palisade Bio Enters Warrant Inducement Agreement
26d ago
8K
PALI
Premium
Company Announcements
Palisade Bio Appoints Emil Chuang as New Director
1M ago
8K
PALI
Premium
The Fly
Palisade Bio appoints to its Board of Directors
1M ago
PALI
Premium
Company Announcements
Palisade Bio Reports Improved Quarterly Losses
3M ago
PALI
Premium
Ratings
Buy Rating for Palisade Bio: Promising Phase 1a Trial Results and Strategic Focus on Unmet Needs in Crohn’s Disease
3M ago
PALI
Premium
The Fly
Palisade Bio files to sell 13.14M shares of common stock, warrants
3M ago
PALI
Premium
The Fly
Palisade Bio reports Phase 1a results for PALI-2108
3M ago
PALI
Premium
Ratings
Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating
3M ago
PALI
Premium
The Fly
Palisade Bio presents preclinical data on PALI-2108
4M ago
PALI
Premium
The Fly
Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108
4M ago
PALI
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ALT
CLLS
Premium
The Fly
Palisade Bio commences dosing in first UC patient cohort in study of PALI-2108
5M ago
PALI
Premium
Pre-Earnings
PALI Upcoming Earnings Report: What to Expect?
5M ago
PALI
Premium
The Fly
Palisade Bio receives cash proceeds from Canada’s SR&ED tax incentive program
6M ago
PALI
Premium
The Fly
Palisade Bio presents preclinical data of PALI-2108
6M ago
PALI
Premium
The Fly
Palisade Bio completes all five SAD cohorts, advanced MAD cohorts for PALI-2108
7M ago
PALI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
